Duodenal adenoma, duodenal mucosal cancer, duodenal NET, duodenal SMT
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Duodenal adenoma, duodenal mucosal cancer (adenocarcinoma), duodenal NET (less than 20 mm, longer axis), duodenal SMT (less than 50 mm, longer axis) 2)Intraluminal developmental form of SMT 3)Performance status o and 1 4)Plt => 100,000/mm3 Creatinine <= 2.0 mg/dl AST <= 200 IU/L ALT <= 200 IU/L T-bil <= 2.0 mg/dl Hb => 8.0 g/dl 5)Patients who gave written informed consent before entry in this study
Exclusion criteria
Exclusion criteria: 1)Ischemic heart disease 2)Liver cirrhosis, active hepatitis 3)Interstitial pneumonia 4)Haemodialysis 5)Both malignant disorder 6)Severe abdominal adhesion 7)Doctor's decision not to register to this regimen
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative one-week complication rates in laparoscopy endoscopy hybrid surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| Surgical process (operative time, intraoperative bleeding, the number of ports, the use of the saturation, cost, the rates of laparotomy transition), postoperative course (oral intake, length of stay, inflammatory findings, the rates of late complications, stenosis). | — |
Countries
Japan
Contacts
Wakayama Medical University Second Department of Surgery